> ## Content Index
> Fetch the complete content index at: https://www.bullished.co/llms.txt
> Use this file to discover other available public pages before exploring further.

# Emily M. Leproust Gets 95,351 Twist Bioscience Shares — Most Still Require Continued Service
- URL: https://www.bullished.co/emily-m-leproust-gets-95-351-twist-bioscience-shares-most-still-require-continued-service-9963e82c/
- Published: 2026-11-16T21:11:15.000Z
- Updated: 2026-11-16T21:11:15.000Z
- Description: The chief executive's performance award was worth an estimated $10.0 million at Monday's close.
- Author: Matteo Parrino
- Tags: Insider Trades, TWST, Industry: Healthcare

Emily M. Leproust, chief executive of [Twist Bioscience](https://www.bullished.co/tag/twst/), which makes synthetic DNA and tools for biology research, received [95,351 shares](https://www.sec.gov/Archives/edgar/data/0001753655/000121465926014385/xslF345X06/marketforms-74295.xml?ref=bullished.co) Thursday after satisfying performance goals. An SEC filing filed Monday put 60% of the award under continued-service requirements.

## A $10 Million Performance Award

The award had an estimated value of $10.0 million at Monday's close. Leproust's reported direct holdings reached 653,538 shares after the grant, worth approximately $68.6 million at Monday's close.

The grant represents about 15% of her reported post-grant holdings. Meeting the performance targets satisfied one condition of the award; most of the shares still carry a service-based vesting condition.

## Sales Preceded The Grant

Leproust's earlier SEC filings recorded sales of 469,459 shares for $75.4 million in the window beginning August 18\. Those totals exclude the latest grant and cover nine sale filings across nine trade days, from August 21 through November 3.

The largest of those sales was on September 17: 356,546 shares for $56.3 million, at approximately $157.99 each. On October 1, she sold 46,391 shares for $8.8 million, at approximately $189.04 each.

TWST shares were up about 252% this year as of Friday's close, when they finished at $111.60\. Twist generated $376.6 million in fiscal 2025 revenue and served more than 3,800 customers globally, selling synthetic biology products, genetic-sequencing tools and antibody discovery services.

## Targets And Staying On

Leproust's earlier equity awards also attached conditions to performance or service. Options granted September 1, 2020, [became exercisable](https://www.sec.gov/Archives/edgar/data/0001753655/000121465926014385/xslF345X06/marketforms-74295.xml?ref=bullished.co) on December 19, 2022, after she satisfied their performance goals.

A separate option award vested 25% on October 24, 2020\. Its schedule called for another 1/48th of the shares to vest on each monthly anniversary, conditional on continuous service.

The remaining 60% of Thursday's award is scheduled to vest on September 30, 2027, provided Leproust continues serving the company.

Learn

- [Code A: a grant or award from the company →](https://www.bullished.co/learn/form-4-transaction-codes-explained/#code-a-a-grant-or-award-from-the-company)  
From Form 4 Transaction Codes Explained: What P, S, M, F, G, J, D And A Mean
- [How To Read A Form 4 SEC Filing, Box By Box →](https://www.bullished.co/learn/how-to-read-form-4-sec-filing/)  
Learn how to read a Form 4 SEC filing: who filed, Table I and II, transaction codes, price, shares owned after, footnotes, and real examples of each case.

### Sources

- [Form 4 — Emily M. Leproust (TWST)](https://www.sec.gov/Archives/edgar/data/0001753655/000121465926014385/xslF345X06/marketforms-74295.xml?ref=bullished.co) — SEC EDGAR

### More on Twist Bioscience

- [Twist Bioscience Stock Plunges 18% After Earnings — Its Market Value Falls By $1.4 Billion](https://www.bullished.co/twist-bioscience-stock-plunges-18-after-earnings-its-market-value-falls-by-1-4-billion-58b7da2e/)
- [Twist Bioscience CEO Calls $100 Million AI Forecast 'Guaranteed' As Analysts Press On Growth](https://www.bullished.co/twist-bioscience-ceo-calls-100-million-ai-forecast-guaranteed-as-analysts-press-on-growth-e5b54bfb/)
- [Twist Bioscience Sales Rise 28% As Quarterly Adjusted EBITDA Turns Positive](https://www.bullished.co/twist-bioscience-sales-rise-28-as-quarterly-adjusted-ebitda-turns-positive-4676c453/)

[All Twist Bioscience (TWST) coverage →](https://www.bullished.co/tag/twst/)